635
Views
54
CrossRef citations to date
0
Altmetric
Review

Sleep disorders: impact on daytime functioning and quality of life

, &
Pages 49-64 | Published online: 09 Jan 2014

References

  • Anderson RT, Aaronson NK, Wilkin D. Critical review of the international assessments of health-related quality of life. Qual. Life Res.2(6), 369–395 (1993).
  • American Academy of Sleep Medicine, in association with the European Sleep Research Society, the Japanese Society of Sleep Research and the Latin American Sleep Society. The International Classification of Sleep Disorders (2nd Edition): Diagnostic and Coding Manual. American Academy of Sleep Medicine, IL, USA (2005).
  • American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (4th Edition). Text Revision (DSM-IVTR®). American Psychiatric Publishing, VA, USA (2000).
  • NIH State-of-the-Science Conference Statement on manifestations and management of chronic insomnia in adults. NIH Consens. State Sci. Statements22(2), 1–30 (2005).
  • Devins GM, Edworthy SM, Paul LC et al. Restless sleep, illness intrusiveness, and depressive symptoms in three chronic illness conditions: rheumatoid arthritis, end-stage renal disease, and multiple sclerosis. J. Psychosom. Res.37(2), 163–170 (1993).
  • Mucsi I, Molnar MZ, Rethelyi J et al. Sleep disorders and illness intrusiveness in patients on chronic dialysis. Nephrol. Dial. Transplant.19(7), 1815–1822 (2004).
  • Taylor DJ, Lichstein KL, Durrence HH. Insomnia as a health risk factor. Behav. Sleep Med.1(4), 227–247 (2003).
  • Phillips B, Mannino DM. Do insomnia complaints cause hypertension or cardiovascular disease? J. Clin. Sleep Med.3(5), 489–494 (2007).
  • Hatoum HT, Kong SX, Kania CM, Wong JM, Mendelson WB. Insomnia, health-related quality of life and healthcare resource consumption. A study of managed-care organisation enrollees. Pharmacoeconomics14(6), 629–637 (1998).
  • Walsh JK, Engelhardt CL. The direct economic costs of insomnia in the United States for 1995. Sleep22(Suppl. 2), S386–S393 (1999).
  • Novak M, Mucsi I, Shapiro CM, Rethelyi J, Kopp MS. Increased utilization of health services by insomniacs – an epidemiological perspective. J. Psychosom. Res.56(5), 527–536 (2004).
  • Manocchia M, Keller S, Ware JE. Sleep problems, health-related quality of life, work functioning and health care utilization among the chronically ill. Qual. Life Res.10(4), 331–345 (2001).
  • Leger D, Poursain B. An international survey of insomnia: under-recognition and under-treatment of a ploysymptomatic condition. Curr. Med. Res. Opin.21(11), 1785–1792 (2005).
  • Chevalier H, Los F, Boichut D et al. Evaluation of severe insomnia in the general population: results of a European multinational survey. J. Psychopharmacol.13(4 Suppl. 1), S21–S24 (1999).
  • Leger D, Guilleminault C, Dreyfus JP, Delahaye C, Paillard M. Prevalence of insomnia in a survey of 12,778 adults in France. J. Sleep Res.9(1), 35–42 (2000).
  • Ohayon MM, Roth T. What are the contributing factors for insomnia in the general population? J. Psychosom. Res.51(6), 745–755 (2001).
  • Pallesen S, Nordhus IH, Nielsen GH et al. Prevalence of insomnia in the adult Norwegian population. Sleep24(7), 771–779 (2001).
  • Ohayon MM. Epidemiology of insomnia: what we know and what we still need to learn. Sleep Med. Rev.6(2), 97–111 (2002).
  • Fulda S, Schulz H. Cognitive dysfunction in sleep disorders. Sleep Med. Rev.5(6), 423–445 (2001).
  • Ancoli-Israel S, Cooke JR. Prevalence and comorbidity of insomnia and effect on functioning in elderly populations. J. Am. Geriatr. Soc.53(Suppl. 7), S264–S271 (2005).
  • Avidan AY. Sleep disorders in the older patient. Prim. Care32(2), 563–586 (2005).
  • Richardson GS, Carskadon MA, Flagg W et al. Excessive daytime sleepiness in man: multiple sleep latency measurement in narcoleptic and control subjects. Electroencephalogr. Clin. Neurophysiol.45(5), 621–627 (1978).
  • Mitler MM, Gujavarty KS, Browman CP. Maintenance of wakefulness test: a polysomnographic technique for evaluation treatment efficacy in patients with excessive somnolence. Electroencephalogr. Clin. Neurophysiol.53(6), 658–661 (1982).
  • Johns MW. A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep14(6), 540–545 (1991).
  • Mahowald ML, Mahowald MW. Nighttime sleep and daytime functioning (sleepiness and fatigue) in well-defined chronic rheumatic diseases. Sleep Med.1(3), 179–193 (2000).
  • Mendelson WB, Garnett D, Gillin JC, Weingartner H. The experience of insomnia and daytime and nighttime functioning. Psychiatry Res.12(3), 235–250 (1984).
  • Lichstein KL, Wilson NM, Noe SL, Aguillard RN, Bellur SN. Daytime sleepiness in insomnia: behavioral, biological and subjective indices. Sleep17(8), 693–702 (1994).
  • Edinger JD, Fins AI, Sullivan RJ Jr et al. Do our methods lead to insomniacs’ madness? Daytime testing after laboratory and home-based polysomnographic studies. Sleep20(12), 1127–1134 (1997).
  • Sateia MJ, Nowell PD. Insomnia. Lancet364(9449), 1959–1973 (2004).
  • Riedel BW, Lichstein KL. Insomnia and daytime functioning. Sleep Med. Rev.4(3), 277–298 (2000).
  • Hauri PJ. Cognitive deficits in insomnia patients. Acta Neurol. Belg.97(2), 113–117 (1997).
  • Breslau N, Roth T, Rosenthal L, Andreski P. Sleep disturbance and psychiatric disorders: a longitudinal epidemiological study of young adults. Biol. Psychiatry39(6), 411–418 (1996).
  • Weissman MM, Greenwald S, Nino-Murcia G, Dement WC. The morbidity of insomnia uncomplicated by psychiatric disorders. Gen. Hosp. Psychiatry19(4), 245–250 (1997).
  • Ford DE, Kamerow DB. Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA262(11), 1479–1484 (1989).
  • Chang PP, Ford DE, Mead LA, Cooper-Patrick L, Klag MJ. Insomnia in young men and subsequent depression. The Johns Hopkins Precursors Study. Am. J. Epidemiol.146(2), 105–114 (1997).
  • Johnson EO, Roth T, Breslau N. The association of insomnia with anxiety disorders and depression: exploration of the direction of risk. J. Psychiatr. Res.40(8), 700–708 (2006).
  • Ohayon MM, Roth T. Place of chronic insomnia in the course of depressive and anxiety disorders. J. Psychiatr. Res.37(1), 9–15 (2003).
  • Roberts RE, Roberts CR, Chen IG. Impact of insomnia on future functioning of adolescents. J. Psychosom. Res.53(1), 561–569 (2002).
  • Gregory AM, Caspi A, Eley TC et al. Prospective longitudinal associations between persistent sleep problems in childhood and anxiety and depression disorders in adulthood. J. Abnorm. Child Psychol.33(2), 157–163 (2005).
  • Neckelmann D, Mykletun A, Dahl AA. Chronic insomnia as a risk factor for developing anxiety and depression. Sleep30(7), 873–880 (2007).
  • Crum RM, Storr CL, Chan YF, Ford DE. Sleep disturbance and risk for alcohol-related problems. Am. J. Psychiatry161(7), 1197–1203 (2004).
  • Roehrs T, Papineau K, Rosenthal L, Roth T. Ethanol as a hypnotic in insomniacs: self administration and effects on sleep and mood. Neuropsychopharmacology20(3), 279–286 (1999).
  • Wong MM, Brower KJ, Fitzgerald HE, Zucker RA. Sleep problems in early childhood and early onset of alcohol and other drug use in adolescence. Alcohol Clin. Exp. Res.28(4), 578–587 (2004).
  • Roberts RE, Roberts CR, Duong HT. Chronic insomnia and its negative consequences for health and functioning of adolescents: a 12-month prospective study. J. Adolesc. Health42(3), 294–302 (2008).
  • Sugerman JL, Stern JA, Walsh JK. Daytime alertness in subjective and objective insomnia: some preliminary findings. Biol. Psychiatry20(7), 741–750 (1985).
  • Morin CM, Stone J, Trinkle D, Mercer J, Remsberg S. Dysfunctional beliefs and attitudes about sleep among older adults with and without insomnia complaints. Psychol. Aging8(3), 463–467 (1993).
  • Bonnet MH, Arand DL. Hyperarousal and insomnia. Sleep Med. Rev.1(2), 97–108 (1997).
  • Chambers MJ, Keller B. Alert insomniacs: are they really sleep deprived? Clin. Psychol. Rev.13(7), 649–666 (1993).
  • Fichten CS, Creti L, Amsel R et al. Poor sleepers who do not complain of insomnia: myths and realities about psychological and lifestyle characteristics of older good and poor sleepers. J. Behav. Med.18(2), 189–223 (1995).
  • Linton SJ, Bryngelsson I. Insomnia and its relationship to work and health in a working-age population. J. Occup. Rehabil.10(2), 169–183 (2000).
  • Sivertsen B, Overland S, Neckelmann D et al. The long-term effect of insomnia on work disability: the HUNT-2 historical cohort study. Am. J. Epidemiol.163(11), 1018–1024 (2006).
  • Carey TJ, Moul DE, Pilkonis P, Germain A, Buysse DJ. Focusing on the experience of insomnia. Behav. Sleep Med.3(2), 73–86 (2005).
  • Ware JE Jr, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med. Care30(6), 473–483 (1992).
  • Byles JE, Mishra GD, Harris MA. The experience of insomnia among older women. Sleep28(8), 972–979 (2005).
  • Hajak G. Epidemiology of severe insomnia and its consequences in Germany. Eur. Arch. Psychiatry Clin. Neurosci.251(2), 49–56 (2001).
  • Katz DA, McHorney CA. The relationship between insomnia and health-related quality of life in patients with chronic illness. J. Fam. Pract.51(3), 229–235 (2002).
  • LeBlanc M, Beaulieu-Bonneau S, Merette C et al. Psychological and health-related quality of life factors associated with insomnia in a population-based sample. J. Psychosom. Res.63(2), 157–166 (2007).
  • Leger D, Scheuermaier K, Philip P, Paillard M, Guilleminault C. SF-36: evaluation of quality of life in severe and mild insomniacs compared with good sleepers. Psychosom. Med.63(1), 49–55 (2001).
  • Schubert CR, Cruickshanks KJ, Dalton DS et al. Prevalence of sleep problems and quality of life in an older population. Sleep25(8), 889–893 (2002).
  • Baldwin CM, Griffith KA, Nieto FJ et al. The association of sleep-disordered breathing and sleep symptoms with quality of life in the Sleep Heart Health Study. Sleep24(1), 96–105 (2001).
  • Zammit GK, Weiner J, Damato N, Sillup GP, McMillan CA. Quality of life in people with insomnia. Sleep22(Suppl. 2), S379–S385 (1999).
  • Dixon S, Morgan K, Mathers N, Thompson J, Tomeny M. Impact of cognitive behavior therapy on health-related quality of life among adult hypnotic users with chronic insomnia. Behav. Sleep Med.4(2), 71–84 (2006).
  • Krystal AD. Treating the health, quality of life, and functional impairments in insomnia. J. Clin. Sleep Med.3(1), 63–72 (2007).
  • Hajak G, Clarenbach P, Fischer W, Haase W, Ruther E. Zopiclone improves sleep quality and daytime wellbeing in insomniac patients: comparison with triazolam, flunitrazepam and placebo. Int. Clin. Psychopharmacol.9(4), 251–261 (1994).
  • Krystal AD, Walsh JK, Laska E et al. Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep26(7), 793–799 (2003).
  • Scharf M, Erman M, Rosenberg R et al. A 2-week efficacy and safety study of eszopiclone in elderly patients with primary insomnia. Sleep28(6), 720–727 (2005).
  • Goldenberg F, Hindmarch I, Joyce C et al. Zopiclone, sleep and health-related quality of life. Hum. Psychopharmacol.9(4), 245–251 (1994).
  • Walsh JK, Krystal AD, Amato DA et al. Nightly treatment of primary insomnia with eszopiclone for six months: effect on sleep, quality of life, and work limitations. Sleep30(8), 959–968 (2007).
  • Walsh JK, Roth T, Randazzo A et al. Eight weeks of non-nightly use of zolpidem for primary insomnia. Sleep23(8), 1087–1096 (2000).
  • Zammit GK, McNabb LJ, Caron J, Amato DA, Roth T. Efficacy and safety of eszopiclone across 6-weeks of treatment for primary insomnia. Curr. Med. Res. Opin.20(12), 1979–1991 (2004).
  • McCall WV, Erman M, Krystal AD et al. A polysomnography study of eszopiclone in elderly patients with insomnia. Curr. Med. Res. Opin.22(9), 1633–1642 (2006).
  • Espie CA, Lindsay WR, Brooks DN, Hood EM, Turvey T. A controlled comparative investigation of psychological treatments for chronic sleep-onset insomnia. Behav. Res. Ther.27(1), 79–88 (1989).
  • Edinger JD, Wohlgemuth WK, Radtke RA, Marsh GR, Quillian RE. Cognitive behavioral therapy for treatment of chronic primary insomnia: a randomized controlled trial. JAMA285(14), 1856–1864 (2001).
  • Omvik S, Sivertsen B, Pallesen S et al. Daytime functioning in older patients suffering from chronic insomnia: treatment outcome in a randomized controlled trial comparing CBT with Zopiclone. Behav. Res. Ther.46(5), 623–641 (2008).
  • Rybarczyk B, Stepanski E, Fogg L et al. A placebo-controlled test of cognitive-behavioral therapy for comorbid insomnia in older adults. J. Consult. Clin. Psychol.73(6), 1164–1174 (2005).
  • Allen RP, Picchietti D, Hening WA et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med.4(2), 101–119 (2003).
  • Montplaisir J, Boucher S, Poirier G et al. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: a study of 133 patients diagnosed with new standard criteria. Mov. Disord.12(1), 61–65 (1997).
  • Ohayon MM, Roth T. Prevalence of restless legs syndrome and periodic limb movement disorder in the general population. J. Psychosom. Res.53(1), 547–554 (2002).
  • Tison F, Crochard A, Leger D et al. Epidemiology of restless legs syndrome in French adults: a nationwide survey: the INSTANT Study. Neurology65(2), 239–246 (2005).
  • Berger K, Luedemann J, Trenkwalder C, John U, Kessler C. Sex and the risk of restless legs syndrome in the general population. Arch. Intern. Med.164(2), 196–202 (2004).
  • Rijsman R, Neven AK, Graffelman W, Kemp B, de Weerd A. Epidemiology of restless legs in The Netherlands. Eur. J. Neurol.11(9), 607–611 (2004).
  • Phillips B, Hening W, Britz P, Mannino D. Prevalence and correlates of restless legs syndrome: results from the 2005 National Sleep Foundation Poll. Chest129(1), 76–80 (2006).
  • Alattar M, Harrington JJ, Mitchell CM, Sloane P. Sleep problems in primary care: a North Carolina Family Practice Research Network (NC-FP-RN) study. J. Am. Board Fam. Med.20(4), 365–374 (2007).
  • Nichols DA, Allen RP, Grauke JH et al. Restless legs syndrome symptoms in primary care: a prevalence study. Arch. Intern. Med.163(19), 2323–2329 (2003).
  • Allen R. Dopamine and iron in the pathophysiology of restless legs syndrome (RLS). Sleep Med.5(4), 385–391 (2004).
  • Manconi M, Govoni V, De Vito A et al. Restless legs syndrome and pregnancy. Neurology63(6), 1065–1069 (2004).
  • Suzuki K, Ohida T, Sone T et al. The prevalence of restless legs syndrome among pregnant women in Japan and the relationship between restless legs syndrome and sleep problems. Sleep26(6), 673–677 (2003).
  • Gemignani F, Brindani F, Negrotti A et al. Restless legs syndrome and polyneuropathy. Mov. Disord.21(8), 1254–1257 (2006).
  • Winkelman JW, Chertow GM, Lazarus JM. Restless legs syndrome in end-stage renal disease. Am. J. Kidney Dis.28(3), 372–378 (1996).
  • Molnar MZ, Novak M, Ambrus C et al. Restless legs syndrome in patients after renal transplantation. Am. J. Kidney Dis.45(2), 388–396 (2005).
  • Mucsi I, Molnar MZ, Ambrus C et al. Restless legs syndrome, insomnia and quality of life in patients on maintenance dialysis. Nephrol. Dial. Transplant.20(3), 571–577 (2005).
  • Benz RL, Pressman MR, Hovick ET, Peterson DD. Potential novel predictors of mortality in end-stage renal disease patients with sleep disorders. Am. J. Kidney Dis.35(6), 1052–1060 (2000).
  • Unruh ML, Levey AS, D’Ambrosio C et al. Restless legs symptoms among incident dialysis patients: association with lower quality of life and shorter survival. Am. J. Kidney Dis.43(5), 900–909 (2004).
  • Molnar MZ, Szentkiralyi A, Lindner A et al. Restless legs syndrome and mortality in kidney transplant recipients. Am. J. Kidney Dis.50(5), 813–820 (2007).
  • Garcia-Borreguero D. Time to REST: epidemiology and burden. Eur. J. Neurol.13(Suppl. 3), 15–20 (2006).
  • Hening W, Walters AS, Allen RP et al. Impact, diagnosis and treatment of restless legs syndrome (RLS) in a primary care population: the REST (RLS epidemiology, symptoms, and treatment) primary care study. Sleep Med.5(3), 237–246 (2004).
  • Van De Vijver DA, Walley T, Petri H. Epidemiology of restless legs syndrome as diagnosed in UK primary care. Sleep Med.5(5), 435–440 (2004).
  • Winkelmann J, Prager M, Lieb R et al. ‘Anxietas tibiarum’. Depression and anxiety disorders in patients with restless legs syndrome. J. Neurol.252(1), 67–71 (2005).
  • Ulfberg J, Nystrom B, Carter N, Edling C. Prevalence of restless legs syndrome among men aged 18 to 64 years: an association with somatic disease and neuropsychiatric symptoms. Mov. Disord.16(6), 1159–1163 (2001).
  • Pennestri MH, Montplaisir J, Colombo R, Lavigne G, Lanfranchi PA. Nocturnal blood pressure changes in patients with restless legs syndrome. Neurology68(15), 1213–1218 (2007).
  • Winkelman JW, Shahar E, Sharief I, Gottlieb DJ. Association of restless legs syndrome and cardiovascular disease in the Sleep Heart Health Study. Neurology70(1), 35–42 (2008).
  • Saletu B, Anderer P, Saletu M et al. EEG mapping, psychometric, and polysomnographic studies in restless legs syndrome (RLS) and periodic limb movement disorder (PLMD) patients as compared with normal controls. Sleep Med.3(Suppl. 3), S35–S42 (2002).
  • Allen RP, Walters AS, Montplaisir J et al. Restless legs syndrome prevalence and impact: REST general population study. Arch. Intern. Med.165(11), 1286–1292 (2005).
  • Rothdach AJ, Trenkwalder C, Haberstock J, Keil U, Berger K. Prevalence and risk factors of RLS in an elderly population: the MEMO study. Memory and Morbidity in Augsburg Elderly. Neurology54(5), 1064–1068 (2000).
  • Lee HB, Hening WA, Allen RP et al. Restless legs syndrome is associated with DSM-IV major depressive disorder and panic disorder in the community. J. Neuropsychiatry Clin. Neurosci.20(1), 101–105 (2008).
  • Sevim S, Dogu O, Kaleagasi H et al. Correlation of anxiety and depression symptoms in patients with restless legs syndrome: a population based survey. J. Neurol. Neurosurg. Psychiatry75(2), 226–230 (2004).
  • Sukegawa T, Itoga M, Seno H et al. Sleep disturbances and depression in the elderly in Japan. Psychiatry Clin. Neurosci.57(3), 265–270 (2003).
  • McCrink L, Allen RP, Wolowacz S et al. Predictors of health-related quality of life in sufferers with restless legs syndrome: a multi-national study. Sleep Med.8(1), 73–83 (2007).
  • Kushida C, Martin M, Nikam P et al. Burden of restless legs syndrome on health-related quality of life. Qual. Life Res.16(4), 617–624 (2007).
  • Abetz L, Allen R, Follet A et al. Evaluating the quality of life of patients with restless legs syndrome. Clin. Ther.26(6), 925–935 (2004).
  • Phillips B, Young T, Finn L et al. Epidemiology of restless legs symptoms in adults. Arch. Intern. Med.160(14), 2137–2141 (2000).
  • Hornyak M, Kopasz M, Berger M, Riemann D, Voderholzer U. Impact of sleep-related complaints on depressive symptoms in patients with restless legs syndrome. J. Clin. Psychiatry66(9), 1139–1145 (2005).
  • Trenkwalder C, Garcia-Borreguero D, Montagna P et al. Ropinirole in the treatment of restless legs syndrome: results from the TREAT RLS 1 study, a 12 week, randomised, placebo controlled study in 10 European countries. J. Neurol. Neurosurg. Psychiatry75(1), 92–97 (2004).
  • Walters AS, Ondo WG, Dreykluft T et al. Ropinirole is effective in the treatment of restless legs syndrome. TREAT RLS 2: a 12-week, double-blind, randomized, parallel-group, placebo-controlled study. Mov. Disord.19(12), 1414–1423 (2004).
  • Patil SP, Schneider H, Schwartz AR, Smith PL. Adult obstructive sleep apnea: pathophysiology and diagnosis. Chest132(1), 325–337 (2007).
  • Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. The report of an American Academy of Sleep Medicine task force. Sleep22(5), 667–689 (1999).
  • Young T, Palta M, Dempsey J et al. The occurrence of sleep-disordered breathing among middle-aged adults. N. Engl. J. Med.328(17), 1230–1235 (1993).
  • Ancoli-Israel S, Kripke DF, Klauber MR et al. Sleep-disordered breathing in community-dwelling elderly. Sleep14(6), 486–495 (1991).
  • Phillips CL, Cistulli PA. Obstructive sleep apnea and hypertension: epidemiology, mechanisms and treatment effects. Minerva Med.97(4), 299–312 (2006).
  • Lavie P, Herer P, Hoffstein V. Obstructive sleep apnoea syndrome as a risk factor for hypertension: population study. BMJ320(7233), 479–482 (2000).
  • Nieto FJ, Young TB, Lind BK et al. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA283(14), 1829–1836 (2000).
  • Arzt M, Young T, Finn L, Skatrud JB, Bradley TD. Association of sleep-disordered breathing and the occurrence of stroke. Am. J. Respir. Crit. Care Med.172(11), 1447–1451 (2005).
  • Mehra R, Benjamin EJ, Shahar E et al. Association of nocturnal arrhythmias with sleep-disordered breathing: The Sleep Heart Health Study. Am. J. Respir. Crit. Care Med.173(8), 910–916 (2006).
  • Arias MA, Sanchez AM. Obstructive sleep apnea and its relationship to cardiac arrhythmias. J. Cardiovasc. Electrophysiol.18(9), 1006–1014 (2007).
  • Marin JM, Carrizo SJ, Vicente E, Agusti AG. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet365(9464), 1046–1053 (2005).
  • Meslier N, Gagnadoux F, Giraud P et al. Impaired glucose-insulin metabolism in males with obstructive sleep apnoea syndrome. Eur. Respir. J.22(1), 156–160 (2003).
  • Decary A, Rouleau I, Montplaisir J. Cognitive deficits associated with sleep apnea syndrome: a proposed neuropsychological test battery. Sleep23(3), 369–381 (2000).
  • Beebe DW, Groesz L, Wells C, Nichols A, McGee K. The neuropsychological effects of obstructive sleep apnea: a meta-analysis of norm-referenced and case–controlled data. Sleep26(3), 298–307 (2003).
  • Kim HC, Young T, Matthews CG et al. Sleep-disordered breathing and neuropsychological deficits. A population-based study. Am. J. Respir. Crit. Care Med.156(6), 1813–1819 (1997).
  • Philip P. Sleepiness of occupational drivers. Ind. Health43(1), 30–33 (2005).
  • Barbe, Pericas J, Munoz A et al. Automobile accidents in patients with sleep apnea syndrome. An epidemiological and mechanistic study. Am. J. Respir. Crit. Care Med.158(1), 18–22 (1998).
  • Sassani A, Findley LJ, Kryger M et al. Reducing motor-vehicle collisions, costs, and fatalities by treating obstructive sleep apnea syndrome. Sleep27(3), 453–458 (2004).
  • Hirshkowitz M, Karacan I, Arcasoy MO et al. Prevalence of sleep apnea in men with erectile dysfunction. Urology36(3), 232–234 (1990).
  • Margel D, Cohen M, Livne PM, Pillar G. Severe, but not mild, obstructive sleep apnea syndrome is associated with erectile dysfunction. Urology63(3), 545–549 (2004).
  • Shiri R, Koskimaki J, Tammela TL et al. Bidirectional relationship between depression and erectile dysfunction. J. Urol.177(2), 669–673 (2007).
  • Martin-Morales A, Meijide F, Garcia N, Artes M, Munoz A. Efficacy of vardenafil and influence on self-esteem and self-confidence in patients with severe erectile dysfunction. J. Sex. Med.4(2), 440–447 (2007).
  • Schroder CM, O’Hara R. Depression and obstructive sleep apnea (OSA). Ann. Gen. Psychiatry4, 13 (2005).
  • Ohayon MM. The effects of breathing-related sleep disorders on mood disturbances in the general population. J. Clin. Psychiatry64(10), 1195–1200; 1274–1296 (2003).
  • Peppard PE, Szklo-Coxe M, Hla KM, Young T. Longitudinal association of sleep-related breathing disorder and depression. Arch. Intern. Med.166(16), 1709–1715 (2006).
  • Borak J, Cieslicki JK, Koziej M, Matuszewski A, Zielinski J. Effects of CPAP treatment on psychological status in patients with severe obstructive sleep apnoea. J. Sleep Res.5(2), 123–127 (1996).
  • Li HY, Huang YS, Chen NH et al. Mood improvement after surgery for obstructive sleep apnea. Laryngoscope114(6), 1098–1102 (2004).
  • Yue W, Hao W, Liu P et al. A case–control study on psychological symptoms in sleep apnea-hypopnea syndrome. Can. J. Psychiatry48(5), 318–323 (2003).
  • Sanchez AI, Buela-Casal G, Bermudez MP, Casas-Maldonado F. The effects of continuous positive air pressure treatment on anxiety and depression levels in apnea patients. Psychiatry Clin. Neurosci.55(6), 641–646 (2001).
  • Pillar G, Lavie P. Psychiatric symptoms in sleep apnea syndrome: effects of gender and respiratory disturbance index. Chest114(3), 697–703 (1998).
  • Sharafkhaneh A, Giray N, Richardson P, Young T, Hirshkowitz M. Association of psychiatric disorders and sleep apnea in a large cohort. Sleep28(11), 1405–1411 (2005).
  • Collop NA, Adkins D, Phillips BA. Gender differences in sleep and sleep-disordered breathing. Clin. Chest Med.25(2), 257–268 (2004).
  • Quintana-Gallego E, Carmona-Bernal C, Capote F et al. Gender differences in obstructive sleep apnea syndrome: a clinical study of 1166 patients. Respir. Med.98(10), 984–989 (2004).
  • Valipour A, Lothaller H, Rauscher H et al. Gender-related differences in symptoms of patients with suspected breathing disorders in sleep: a clinical population study using the sleep disorders questionnaire. Sleep30(3), 312–319 (2007).
  • Flemons WW, Reimer MA. Development of a disease-specific health-related quality of life questionnaire for sleep apnea. Am. J. Respir. Crit. Care Med.158(2), 494–503 (1998).
  • Moyer CA, Sonnad SS, Garetz SL, Helman JI, Chervin RD. Quality of life in obstructive sleep apnea: a systematic review of the literature. Sleep Med.2(6), 477–491 (2001).
  • Lacasse Y, Godbout C, Sériès F. Health-related quality of life in obstructive sleep apnoea. Eur. Respir. J.19(3), 499–503 (2002).
  • Goncalves MA, Paiva T, Ramos E, Guilleminault C. Obstructive sleep apnea syndrome, sleepiness, and quality of life. Chest125(6), 2091–2096 (2004).
  • Finn L, Young T, Palta M, Fryback DG. Sleep-disordered breathing and self-reported general health status in the Wisconsin Sleep Cohort Study. Sleep21(7), 701–706 (1998).
  • Akashiba T, Kawahara S, Akahoshi T et al. Relationship between quality of life and mood or depression in patients with severe obstructive sleep apnea syndrome. Chest122(3), 861–865 (2002).
  • Sforza E, Janssens JP, Rochat T, Ibanez V. Determinants of altered quality of life in patients with sleep-related breathing disorders. Eur. Respir. J.21(4), 682–687 (2003).
  • Yang EH, Hla KM, McHorney CA et al. Sleep apnea and quality of life. Sleep23(4), 535–541 (2000).
  • Wang PC, Li HY, Shih TS et al. Generic and specific quality-of-life measures in Taiwanese adults with sleep-disordered breathing. Otolaryngol. Head Neck Surg.135(3), 421–426 (2006).
  • Glebocka A, Kossowska A, Bednarek M. Obstructive sleep apnea and the quality of life. J. Physiol Pharmacol.57(Suppl. 4), 111–117 (2006).
  • Briones B, Adams N, Strauss M et al. Relationship between sleepiness and general health status. Sleep19(7), 583–588 (1996).
  • Sforza E, de Saint Hilaire Z, Pelissolo A, Rochat T, Ibanez V. Personality, anxiety and mood traits in patients with sleep-related breathing disorders: effect of reduced daytime alertness. Sleep Med.3(2), 139–145 (2002).
  • Weaver TE, Laizner AM, Evans LK et al. An instrument to measure functional status outcomes for disorders of excessive sleepiness. Sleep20(10), 835–843 (1997).
  • Cassel W. Sleep apnea and personality. Sleep16(Suppl. 8), S56–S58 (1993).
  • Bardwell WA, Berry CC, Ancoli-Israel S, Dimsdale JE. Psychological correlates of sleep apnea. J. Psychosom. Res.47(6), 583–596 (1999).
  • Patel SR, White DP, Malhotra A, Stanchina ML, Ayas NT. Continuous positive airway pressure therapy for treating sleepiness in a diverse population with obstructive sleep apnea: results of a meta-analysis. Arch. Intern. Med.163(5), 565–571 (2003).
  • Schwartz DJ, Karatinos G. For individuals with obstructive sleep apnea, institution of CPAP therapy is associated with an amelioration of symptoms of depression which is sustained long term. J. Clin. Sleep Med.3(6), 631–635 (2007).
  • Kawahara S, Akashiba T, Akahoshi T, Horie T. Nasal CPAP improves the quality of life and lessens the depressive symptoms in patients with obstructive sleep apnea syndrome. Intern. Med.44(5), 422–427 (2005).
  • Kjelsberg FN, Ruud EA, Stavem K. Predictors of symptoms of anxiety and depression in obstructive sleep apnea. Sleep Med.6(4), 341–346 (2005).
  • Wells RD, Freedland KE, Carney RM, Duntley SP, Stepanski EJ. Adherence, reports of benefits, and depression among patients treated with continuous positive airway pressure. Psychosom. Med.69(5), 449–454 (2007).
  • Yamamoto H, Akashiba T, Kosaka N, Ito D, Horie T. Long-term effects nasal continuous positive airway pressure on daytime sleepiness, mood and traffic accidents in patients with obstructive sleep apnoea. Resp. Med.94(1), 87–90 (2000).
  • Ferini-Strambi L, Baietto C, Di Gioia MR et al. Cognitive dysfunction in patients with obstructive sleep apnea (OSA): partial reversibility after continuous positive airway pressure (CPAP). Brain Res. Bull.61(1), 87–92 (2003).
  • Ulfberg J, Carter N, Talback M, Edling C. Adverse health effects among women living with heavy snorers. Health Care Women Int.21(2), 81–90 (2000).
  • Parish JM, Lyng PJ. Quality of life in bed partners of patients with obstructive sleep apnea or hypopnea after treatment with continuous positive airway pressure. Chest124(3), 942–947 (2003).
  • Costa G. Shift work and occupational medicine: an overview. Occup. Med. (Lond.)53(2), 83–88 (2003).
  • United States Bureau of Labor Statistics. Workers on Flexible and Shift Schedules in May 2004. United States Department of Labor, Bureau of Labor Statistics, DC, USA (2004).
  • Frank JR, Ovens H. Shiftwork and emergency medical practice. CJEM4(6), 421–428 (2002).
  • Ohayon MM, Lemoine P, Arnaud-Briant V, Dreyfus M. Prevalence and consequences of sleep disorders in a shift worker population. J. Psychosom. Res.53(1), 577–583 (2002).
  • Knutsson A. Health disorders of shift workers. Occup. Med. (Lond.)53(2), 103–108 (2003).
  • Labyak S, Lava S, Turek F, Zee P. Effects of shiftwork on sleep and menstrual function in nurses. Health Care Women Int.23(6–7), 703–714 (2002).
  • Baker FC, Driver HS. Circadian rhythms, sleep, and the menstrual cycle. Sleep Med.8(6), 613–622 (2007).
  • Schwartz JR, Roth T. Shift work sleep disorder: burden of illness and approaches to management. Drugs66(18), 2357–2370 (2006).
  • Drake CL, Roehrs T, Richardson G, Walsh JK, Roth T. Shift work sleep disorder: prevalence and consequences beyond that of symptomatic day workers. Sleep27(8), 1453–1462 (2004).
  • Driscoll TR, Grunstein RR, Rogers NL. A systematic review of the neurobehavioural and physiological effects of shiftwork systems. Sleep Med. Rev.11(3), 179–194 (2007).
  • Akerstedt T. Shift work and disturbed sleep/wakefulness. Occup. Med. (Lond.)53(2), 89–94 (2003).
  • Tepas DI, Barnes-Farrell JL, Bobko N et al. The impact of night work on subjective reports of wellbeing: an exploratory study of health care workers from five nations. Rev. Saude Publica38(Suppl.), 26–31 (2004).
  • Winwood PC, Winefield AH, Lushington K. Work-related fatigue and recovery: the contribution of age, domestic responsibilities and shiftwork. J. Adv. Nurs.56(4), 438–449 (2006).
  • Petrilli RM, Jay SM, Dawson D, Lamond N. The impact of sustained wakefulness and time-of-day on OSPAT performance. Ind. Health43(1), 186–192 (2005).
  • Cho K, Ennaceur A, Cole JC, Suh CK. Chronic jet lag produces cognitive deficits. J. Neurosci.20(6), RC66 (2000).
  • Rouch I, Wild P, Ansiau D, Marquie JC. Shiftwork experience, age and cognitive performance. Ergonomics48(10), 1282–1293 (2005).
  • Folkard S, Tucker P. Shift work, safety and productivity. Occup. Med. (Lond.)53(2), 95–101 (2003).
  • van Amelsvoort LG, Jansen NW, Swaen GM, van den Brandt PA, Kant I. Direction of shift rotation among three-shift workers in relation to psychological health and work-family conflict. Scand. J. Work Environ. Health30(2), 149–156 (2004).
  • Presser HB. Nonstandard work schedules and marital instability. J. Marriage Family62(1), 93–100 (2000).
  • Escriba-Aguir V. Nurses’ attitudes towards shiftwork and quality of life. Scand. J. Soc. Med.20(2), 115–118 (1992).
  • Smith L, Folkard S. The perceptions and feelings of shiftworkers’ partners. Ergonomics36(1–3), 299–305 (1993).
  • Demerouti E, Geurts SA, Bakker AB, Euwema M. The impact of shiftwork on work – home conflict, job attitudes and health. Ergonomics47(9), 987–1002 (2004).
  • Waeckerle JF. Circadian rhythm, shift work, and emergency physicians. Ann. Emerg. Med.24(5), 959–961 (1994).
  • Kandolin I. Burnout of female and male nurses in shiftwork. Ergonomics36(1–3), 141–147 (1993).
  • Van Dongen HP, Baynard MD, Maislin G, Dinges DF. Systematic interindividual differences in neurobehavioral impairment from sleep loss: evidence of trait-like differential vulnerability. Sleep27(3), 423–433 (2004).
  • Pilcher JJ, Lambert BJ, Huffcutt AI. Differential effects of permanent and rotating shifts on self-report sleep length: a meta-analytic review. Sleep23(2), 155–163 (2000).
  • Kivimaki M, Kuisma P, Virtanen M, Elovainio M. Does shift work lead to poorer health habits? A comparison between women who had always done shift work with those who had never done shift work. Work Stress15(1), 3–13 (2001).
  • Smith L, Tanigawa T, Takahashi M et al. Shiftwork locus of control, situational and behavioural effects on sleepiness and fatigue in shiftworkers. Ind. Health43(1), 151–170 (2005).
  • Kaliterna LL, Prizmic LZ, Zganec N. Quality of life, life satisfaction and happiness in shift- and non-shiftworkers. Rev. Saude Publica38(Suppl.), 3–10 (2004).
  • Takahashi M. The role of prescribed napping in sleep medicine. Sleep Med. Rev.7(3), 227–235 (2003).
  • Noordzij M, Uiterwaal CS, Arends LR et al. Blood pressure response to chronic intake of coffee and caffeine: a meta-analysis of randomized controlled trials. J. Hypertens.23(5), 921–928 (2005).
  • Lemmer B. The sleep-wake cycle and sleeping pills. Physiol. Behav.90(2–3), 285–293 (2007).
  • Czeisler CA, Walsh JK, Roth T et al. Modafinil for excessive sleepiness associated with shift-work sleep disorder. N. Engl. J. Med.353(5), 476–486 (2005).
  • Erman MK, Rosenberg R; The US Modafinil Shift Work Sleep Disorder Study Group. Modafinil for excessive sleepiness associated with chronic shift work sleep disorder: effects on patient functioning and health-related quality of life. Prim. Care Companion J. Clin. Psychiatry9(3), 188–194 (2007).
  • Kerin A, Aguirre A. Improving health, safety, and profits in extended hours operations (shiftwork). Ind. Health43(1), 201–208 (2005).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.